Prosecution Insights
Last updated: April 19, 2026

Peter Maccallum Cancer Institute

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18572665 CONDUCTOMETRIC SENSOR FOR DETECTING A NUCLEIC ACID AND A METHOD FOR THE DETECTION THEREOF KAUR, GURPREET 1759 Non-Final OA Dec 20, 2023
18013729 NITROGEN-CONTAINING ANALOGS OF SALINOMYCIN FOR USE IN ACUTE MYELOID LEUKEMIA STEVENS, MARK V 1613 Final Rejection Dec 29, 2022
17780658 Methods of activating cytotoxic leukocytes using PTP1B and PTPN2 inhibitors MIANO, JOSEPH PAUL 1631 Non-Final OA May 27, 2022

Managing Peter Maccallum Cancer Institute's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month